AI assistant
REVVITY, INC. — Director's Dealing 2015
Feb 4, 2015
30616_dirs_2015-02-04_29b53b8e-2e76-4e66-8574-31c625832be8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PERKINELMER INC (PKI)
CIK: 0000031791
Period of Report: 2015-02-03
Reporting Person: FRIEL ROBERT F (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-03 | Common Stock | M | 60709 | $12.945 | Acquired | 593019 | Direct |
| 2015-02-03 | Common Stock | S | 60709 | $46.259 | Disposed | 532310 | Direct |
| 2015-02-03 | Common Stock | A | 36835 | $0.00 | Acquired | 569145 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-03 | NQ Stock Option (right to buy) | $12.945 | M | 60709 | Disposed | 2016-02-03 | Common Stock (60709) | Direct |
| 2015-02-03 | NQ Stock Option (right to buy) | $46.83 | A | 156818 | Acquired | 2022-02-03 | Common Stock (156818) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Friel on December 4, 2014.
F2: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $45.710 to $46.490. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F3: Shares are time-based restricted stock that will vest in full on the third anniversary of the date of grant.
F4: This option became exercisable in three equal annual installments beginning on February 3, 2010, which was the first anniversary of the date on which the option was granted.
F5: This option vests in three equal annual installments beginning on the first anniversary of the date of grant, and has a 7 year exercise term.